The Week’s 10 Biggest Funding Rounds: Whatnot Goes Big; TAE Powers Up With $250M – Rounds raised by U.S.-based startups were big this week, with three topping $200 million. No one category stood out, as investors wrote checks for anything ranging from livestream shopping to biotech to ways to develop clean drinking water. After a slow start to the month, large rounds have come back into play for some startups.
Tessera Therapeutics stacks up more than $300M in series C funds to bolster new gene-editing platforms – Tessera Therapeutics, founded and created by life sciences VC staple Flagship Pioneering, is building a war chest with a fresh $300 million for its trio of gene writing platforms.
This Beverly Hills Startup Just Raised Millions to Help Brands Mint NFTs – A new blockchain startup called NFT Brands has unveiled a $3.6 million seed funding round today as it barrels into the $40 billion-plus market for non-fungible tokens.
The Beverly Hills-based company is aiming to launch “multimillion-dollar NFT projects” for brands and celebrities, according to founder and CEO Noah Loul. NFT Brands closed the seed round in under two weeks, Loul said, and is now turning its attention to a targeted $35 million Series A round that is slated to open to investors today.
Congruence pulls in $50M series A to build a team of ‘drug hunters’ to go after rare disease targets – A new biotech called Congruence Therapeutics snagged $50 million to build a new team of “drug hunters” focused on protein misfolding to go after rare diseases.
Satellite Intelligence Company Astraea Secures $6.5M Series A Funding – CHARLOTTESVILLE, Va., July 22, 2022 (GLOBE NEWSWIRE) — Astraea, Inc. (Astraea), a satellite intelligence company, today closed an oversubscribed $6.5 million Series A round led by Aligned Climate Capital and Carbon Drawdown Collective with participation from CAV Angels, Tydall Investment Partners, and existing investor University of Virginia (UVA) Seed Fund.
Theator Raises Additional $24M in Series A Funding – Theator, a Palo Alto, CA-based provider of a Surgical Intelligence platform, raised $24M in additional Series A funding.